Shopping Cart

Remove All

Your shopping cart is currently empty

Ormutivimab

Resource Download

Ormutivimab

Catalog No. T80594Cas No. 2449086-91-1

Ormutivimab (rhRIG), a recombinant human monoclonal antibody designed to target the rabies virus, effectively neutralizes various strains and demonstrates strong efficacy as a post-exposure prophylaxis (PEP) treatment in model studies [1] [2].

All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Pack Size	Price	Availability	Quantity
1 mg	Inquiry	Backorder
5 mg	Inquiry	Backorder

Bulk & Custom

Add to Cart

Questions

Product Introduction

Bioactivity

Description	Ormutivimab (rhRIG), a recombinant human monoclonal antibody designed to target the rabies virus, effectively neutralizes various strains and demonstrates strong efficacy as a post-exposure prophylaxis (PEP) treatment in model studies [1] [2].
In vivo	Ormutivimab, at a single dose of 20 IU/kg administered via intramuscular injection, conferred protection to beagles against the lethal challenge of RABV BD06. Similarly, a single intramuscular injection of Ormutivimab, at dosages of 20 IU/kg and 100 IU/kg, provided protective immunity to Kunming mice subjected to various rabies virus strains.
Alias	rhRIG, NM57

Chemical Properties

Cas No.

2449086-91-1

Storage & Solubility Information

Storage

Calculator

Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:

For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments

A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent

DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。

Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSO TargetMol | reagent

(mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.

Preparation method for in vivo formula: Take 50 μL DMSO TargetMol | reagent

main solution, add 300 μLPEG300 TargetMol | reagent

mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2O TargetMol | reagent

mix well and clarify

Dose Conversion

You can also refer to dose conversion for different animals. More

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Related Tags: buy Ormutivimab | purchase Ormutivimab | Ormutivimab cost | order Ormutivimab | Ormutivimab in vivo